...human genes into them for expression in the mammary gland. GZTC has production deals with Centocor Diagnostics Inc....

...Hired: James Danehy, as vice-chairman, president and CEO upon his completion of CEO duties with Centocor Diagnostics...

...the transfer of BIOMF's Truquant blood test kits for breast, ovarian and gastrointestinal cancers to Centocor Diagnostics...
...could receive $300,000 in milestones under the asset purchase agreement. Biomira Inc. (BIOMF), Edmonton, Alberta Centocor Diagnostics Inc....

...CNTO said it is evaluating strategic options for its Centocor Diagnostics subsidiary, including possible sale of the...
...subsidiary, including possible sale of the business, in order to focus on its pharmaceutical business. Centocor Diagnostics...

...will sell its Truquant blood test kits to detect breast, ovarian and gastrointestinal cancers to Centocor Diagnostics...
...operations by Aug. 28, and would lay off 49 employees. Biomira Inc. (BIOMF), Edmonton, Alberta Centocor Diagnostics Inc....

...bad to terrible," von Emster said. Several companies recently postponed or withdrew offerings - including Centocor Diagnostics...

...down nearly 22 percent since early October), three IPOs fell victim to the soft market. Centocor Diagnostics...
...deals on ice. Illustrating the general malaise in biotech, each deal represented a different territory: Centocor Diagnostics...
...NASDAQ deal, RTP was to price in Canada, and Cerep was in France's Nouveau Marche. Centocor Diagnostics...

...consolidation of research programs of Amoco Corp., which will own 63 percent after the IPO. Centocor Diagnostics...
...Centocor (CNTO), filed to raise up to $40 million. CNTO would own 80 percent post-IPO. Centocor Diagnostics...